Navigation Links
Mylan Receives Approval for Generic Version of MS Contin® Tablets
Date:10/27/2011

PITTSBURGH, Oct. 27, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Morphine Sulfate Extended-release (ER) Tablets, 15 mg, 30 mg, 60 mg, 100 mg and 200 mg, the generic version of Purdue Pharma's MS Contin®, an opioid analgesic for moderate to severe pain management.  

Morphine Sulfate ER Tablets had U.S. sales of approximately $173 million for the 12 months ending June 30, 2011, according to IMS Health. Mylan is launching this product immediately.

Currently, Mylan has 163 ANDAs pending FDA approval representing $97.5 billion in annual sales, according to IMS Health. Forty-four of these pending ANDAs are potential first-to-file opportunities, representing $26.9 billion in annual brand sales, for the 12 months ending June 30, 2011, according to IMS Health.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit www.ChoosingGenerics.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Mylan Launches First Generic Version of Exelon® Capsules in the U.K.
2. Mylans Dey Pharma Successfully Obtains Patent Reexamination Certificates for Two Perforomist® Patents
3. Matrix Laboratories Completes Name Change to Mylan Laboratories
4. Mylan Announces Femcon® Fe Settlement Agreement
5. Mylan Announces Intention to Refinance Existing Secured Credit Facility
6. Mylan Comments on Death of Company Co-Founder and Former Chairman and CEO Milan "Mike" Puskar
7. Mylan Applauds Study Highlighting $931 Billion in Savings for U.S. Health Care System Due to Generic Drugs
8. Mylan Announces XELODA® Settlement and License Agreement
9. Mylans Matrix Receives Tentative FDA Approval Through PEPFAR for Novel "Co-Packaged" Version of HIV/AIDS Treatment
10. Mylan Launches Generic Version of Uroxatral® Tablets
11. Mylan Announces U.S. PTO Intends to Reissue Two Perforomist® Patents to Dey Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014 /PRNewswire-iReach/ -- Inc. ... for the third straight year, No. 349 in ... exclusive ranking of the nation,s fastest-growing private companies. ... the most important segment of the economy—America,s independent ... Domino,s Pizza, LinkedIn, Zillow, and many other well-known ...
(Date:8/21/2014)... YORK , August 21, 2014 ... Israeli subsidiary, BreedIT Ltd., the exclusive worldwide license ... software for plant breeders and researchers, today is ... a joint venture with Seach Ltd, a leading ... formed to research and develop new breeds of ...
(Date:8/21/2014)... 2014  AliveCor, Inc. announced today that ... has granted the company clearance for its ... most common form of cardiac arrhythmia. AliveCor,s ... patients are experiencing AFib through real-time electrocardiogram ... based AliveCor® Heart Monitor, so physicians can ...
Breaking Medicine Technology:Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 4AliveCor Receives First FDA Clearance to Detect a Serious Heart Condition in an ECG on a Mobile Device 2
... Pharmaceuticals announced that Richard Kent, M.D., a partner at ... directors.  Dr. Kent will replace Garheng Kong, M.D., Ph.D., ... Kong, who has recently taken a position as a ... chairman of the board. Dr. Kent brings ...
... Reportlinker.com announces that a new market research ... Active Pharmaceutical Ingredients (APIs) Market to ... Sector will Sustain Growth ... Ingredients (APIs) Market to 2015 - Rise in ...
Cached Medicine Technology:Cempra Pharmaceuticals Names Richard Kent, M.D., to Its Board of Directors 2Reportlinker Adds Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth 2Reportlinker Adds Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth 3Reportlinker Adds Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth 4Reportlinker Adds Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth 5Reportlinker Adds Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth 6Reportlinker Adds Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth 7Reportlinker Adds Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth 8Reportlinker Adds Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth 9Reportlinker Adds Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth 10Reportlinker Adds Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth 11Reportlinker Adds Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth 12Reportlinker Adds Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth 13Reportlinker Adds Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth 14Reportlinker Adds Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth 15Reportlinker Adds Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth 16Reportlinker Adds Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth 17
(Date:8/21/2014)... chronic kidney disease patients may be a strong indicator ... in the Journal of the American Society of ... Hopkins Bloomberg School of Public Health assert that coronary ... atherosclerosis in predicting the risk of heart disease among ... all patients with chronic kidney disease (CKD) die from ...
(Date:8/21/2014)... Health System and The University of Texas MD Anderson ... a new level of specialized breast screening at a ... Houston area. , Starting in late November, MD Anderson ... services for five of Memorial Hermann,s 10 breast care ... and Sugar Land. , Over time, the network will ...
(Date:8/21/2014)... only is eating better and exercising healthy for people with ... year, a new study finds. The study, led by ... Forest Baptist Medical Center in Winston-Salem, N.C., included more ... Participants ranged in age from 45 to 76, ... program" focused on diet and exercise, or to a standard ...
(Date:8/21/2014)... August 21, 2014 Transvaginal mesh ... Inc. continue to move forward in the federal ... District of West Virginia, Bernstein Liebhard LLP reports. ... 14th, the Court has established new stipulated evidence ... handling, division, storage and preservation. (In re C.R. ...
(Date:8/21/2014)... FRANCISCO Aug. 21, 2014 Researchers in the ... congenital cataracts can quickly and accurately diagnose a number ... a study published online today in ... Ophthalmology. Using a single test, doctors were able ... on their mutations reducing the time and money spent ...
Breaking Medicine News(10 mins):Health News:Measuring calcium buildup to predict heart disease in those with chronic kidney disease 2Health News:MD Anderson and Memorial Hermann to operate breast screening network across Houston area 2Health News:Getting Healthier a Big Money-Saver for People With Diabetes 2Health News:Transvaginal Mesh Lawsuits Move Forward in Federal C.R. Bard Litigation with Issuance of New Pretrial Order, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward in Federal C.R. Bard Litigation with Issuance of New Pretrial Order, Bernstein Liebhard LLP Reports 3Health News:New DNA test for diagnosing diseases linked to childhood blindness 2
... People who suffer cardiac arrests and then receive coronary ... brain damage compared with those who don,t have the ... School of Medicine researchers. The study, published in the ... Medicine and now available online, showed that patient ...
... March 31 Responding to negative impacts on clinician productivity and ... Inc. ( www.usercentric.com ) - a ... service offering specifically for health care organizations (HCOs) : ... clinicians are struggling to adopt EHRs because they are too time-consuming ...
... Research (IADR) announces Dr. Anthony Fauci, director, National Institute ... Institutes of Health in Bethesda, Md., USA as 2009 ... at the 87th General Session & Exhibition in Miami, ... Dr. Fauci became director of NIAID, where he oversees ...
... of Cosmetic Surgery 2008 Procedural Survey shows a 2% ... the first time in several years, male cosmetic surgery ... of Cosmetic Surgery (AACS), a leader in the cosmetic ... survey reveals that males are cutting back on cosmetic ...
... The not-for-profit LENA Foundation is putting forth a ... Society of Research in Child Development (SRCD). At the ... one poster will be presented based on findings using ... SRCD is a great opportunity for our colleagues to ...
... FRAMINGHAM, Mass., March 31 Courion(R) Corporation ... today announced that Kurt Johnson, vice president of corporate ... leader of technical management, will deliver a presentation entitled ... Compliance," at the HIMSS 09 Annual Conference ...
Cached Medicine News:Health News:Coronary angiography may improve outcomes for cardiac arrest patients 2Health News:Coronary angiography may improve outcomes for cardiac arrest patients 3Health News:User Centric to Address EHR Usability With New Service Offering 2Health News:User Centric to Address EHR Usability With New Service Offering 3Health News:Male Cosmetic Surgery Slows Down While Female Cosmetic Surgery Advances 2Health News:Five Research Studies at International SRCD Meeting in Denver Use Technology from Boulder Foundation 2Health News:Five Research Studies at International SRCD Meeting in Denver Use Technology from Boulder Foundation 3Health News:Courion and Alegent Health to Discuss HIPAA and Next-Generation Healthcare Portals at HIMSS 09 Annual Conference and Exhibition 2
...
...
... antimony pH catheters are designed for patient comfort ... catheters are number marked at 5cm intervals and ... sixteen individual models are available spanning most clinical ... multi-use models with one or two sensors., ...
... designed for patient comfort as well as dependable ... at 5cm intervals and line marked each centimeter., ... available spanning most clinical needs and the range ... or two sensors., ,A range of four ...
Medicine Products: